| Literature DB >> 35875666 |
Haoli Mao1, Jiao Zhu1, Yanyong Cheng1, Lingling Shi1, Xiao Chen1, Ren Zhou1, Zhenyu Xue1, Siyu Liu1, Zilong Qiu2, Hong Jiang1.
Abstract
Objective: In the lipid-rich brain, lipids performed signaling processes associated with the control system of the cell cycle, stress, and inflammatory reactions, as well as maintained brain and cellular homeostasis. The effects of general anesthesia on brain impairment in the elderly were controversial and complex. The study sought to evaluate the effect of lipid metabolism in the brain of aged marmosets and mice under long-term exposure to sevoflurane.Entities:
Keywords: brain; general anesthesia; lipid metabolism; marmosets; mice; sevoflurane
Year: 2022 PMID: 35875666 PMCID: PMC9298509 DOI: 10.3389/fnmol.2022.915570
Source DB: PubMed Journal: Front Mol Neurosci ISSN: 1662-5099 Impact factor: 6.261
FIGURE 1Analysis of lipidomics in the prefrontal cortex of aged marmosets. (A) Two-dimensional score diagram of PCA analysis of sevoflurane anesthesia group and control group in prefrontal cortex of aged marmosets. (B) Pairwise score chart of the top five principal components of PCA. (C) PLS-DA 2D score chart. (D) Permutation test results of PLS-DA Model 1000 times. (E) OPLS-DA 2D score chart. (F) The top 15 lipids ranked by VIP value of the OPLD-DA model. (G) In volcano analysis, red dots indicated the lipid components significantly increased in the sevoflurane group compared with the control group (fold-change > 1.2, P < 0.05); blue dots indicated obviously lower lipid components in the sevoflurane group (fold-change < 0.83, P < 0.05).
Differential lipids in marmosets.
| Lipid | Fold-change | Log2Fold-change | VIP | |
| PC (18:1/22:5) + AcO | 1.385 | 0.470 | 0.001 | 2.508 |
| PE (18:0/22:5) | 1.524 | 0.608 | 0.002 | 2.476 |
| PI (18:1/20:4) | 0.850 | –0.235 | 0.004 | 2.438 |
| PI (20:0/18:1) | 0.855 | –0.226 | 0.004 | 2.406 |
| LPE (22:5) | 2.038 | 1.027 | 0.010 | 2.319 |
| TAG56:5-FA20:4 | 0.663 | –0.593 | 0.015 | 2.270 |
| PE (16:0/22:5) | 1.568 | 0.649 | 0.019 | 2.284 |
| PE (18:1/22:5) | 1.539 | 0.622 | 0.022 | 2.259 |
| PE (18:2/22:5) | 1.499 | 0.584 | 0.028 | 2.216 |
| PC (20:0/20:4) + AcO | 0.691 | –0.534 | 0.028 | 2.200 |
| TAG58:10-FA22:6 | 0.465 | –1.104 | 0.029 | 2.179 |
| PC (18:1/22:6) + AcO | 0.814 | –0.297 | 0.030 | 2.176 |
| PC (18:1/20:5) + AcO | 0.382 | –1.388 | 0.031 | 2.181 |
| PI (20:0/20:4) | 0.772 | –0.374 | 0.032 | 2.149 |
| PE (16:0/18:1) | 1.124 | 0.169 | 0.034 | 2.121 |
| PE (14:0/22:5) | 1.646 | 0.719 | 0.035 | 2.187 |
| TAG60:10-FA22:6 | 0.566 | –0.822 | 0.040 | 2.127 |
| PE (P-18:2/22:6) | 0.778 | –0.362 | 0.040 | 2.104 |
| PC (20:0/16:1) + AcO | 0.766 | –0.385 | 0.041 | 2.138 |
| TAG54:2-FA20:0 | 1.741 | 0.800 | 0.041 | 2.077 |
| TAG56:7-FA22:6 | 0.739 | –0.436 | 0.043 | 2.127 |
| TAG54:6-FA22:6 | 0.697 | –0.521 | 0.045 | 2.116 |
| PI (16:0/20:2) | 1.278 | 0.354 | 0.046 | 2.106 |
| PA (20:0/22:5) | 1.399 | 0.484 | 0.048 | 2.113 |
| DAG (16:0/22:5) | 1.416 | 0.502 | 0.049 | 2.065 |
The lipids that met both OPLS-DA analysis screening criteria (VIP > 1) and volcano plot analysis screening criteria (P < 0.05) were selected as the lipid components with significant difference.
FIGURE 2Analysis of lipidomics in the prefrontal cortex of aged mice. (A) Two-dimensional score diagram of PCA analysis of sevoflurane anesthesia group and control group in prefrontal cortex of aged mice. (B) Pairwise score chart of the top five principal components of PCA. (C) PLS-DA 2D score chart. (D) Permutation test results of PLS-DA Model 1000 times. (E) OPLS-DA 2D score chart. (F) The top 15 lipids ranked by VIP value of the OPLD-DA model. (G) In volcano analysis, red dots indicated the lipid components significantly increased in the sevoflurane group compared with the control group (fold-change > 1.2, P < 0.05); blue dots indicate significantly lower lipid components in the sevoflurane group (fold-change < 0.83, P < 0.05).
Differential lipids in mice.
| Lipid | Fold-change | Log2Fold-change | VIP | |
| PA (18:1/20:2) | 1.538 | 0.621 | 0.007 | 2.922 |
| PE (14:0/22:4) | 0.514 | –0.961 | 0.013 | 2.850 |
| LPC (16:1) + AcO | 0.752 | –0.411 | 0.018 | 2.669 |
| TAG52:5-FA20:4 | 1.473 | 0.558 | 0.021 | 2.726 |
| DAG (16:1/18:2) | 0.732 | –0.450 | 0.023 | 2.694 |
The lipids that meet both OPLS-DA analysis screening criteria (VIP > 1) and volcano plot analysis screening criteria (P < 0.05) were selected as the lipid components with significant difference.
FIGURE 3Analysis of lipid metabolic pathways in marmosets and mice. (A) Lipid metabolic pathways in marmosets. (B) Lipid metabolic pathways in mice.
FIGURE 4Analysis of lipid differences between marmosets and mice in control group and sevoflurane group. (A) Heat map of differential lipids in the top 20 of control groups between marmosets and mice. (B) Heat map of differential lipids in the top 20 of sevoflurane groups between marmosets and mice. (C) Venn plot analysis. (D) Subclass enrichment analysis.